Your browser doesn't support javascript.
loading
Systematic review reveals urgent need to homogenize endpoints choices and definitions in marginal zone lymphomas trials.
Bommier, Côme; Ruggiu, Mathilde; Monégier, Aymeric; Zucca, Emanuele; Thieblemont, Catherine; Lambert, Jérôme.
Affiliation
  • Bommier C; Hemato-Oncology Department, DMU DHI, Hôpital Saint Louis, Paris, France.
  • Ruggiu M; Inserm U1153 - ECSTRRA Team, Paris, France.
  • Monégier A; Université de Paris, Paris, France.
  • Zucca E; Biostatistics and Medical Information Department, Saint Louis Hospital, Paris, France.
  • Thieblemont C; Hematopoietic Allograft Department, Hôpital Saint Louis, Paris, France.
  • Lambert J; Biostatistics and Medical Information Department, Saint Louis Hospital, Paris, France.
Leuk Lymphoma ; 63(7): 1544-1555, 2022 07.
Article in En | MEDLINE | ID: mdl-35201907

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell, Marginal Zone Type of study: Clinical_trials / Systematic_reviews Limits: Child / Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell, Marginal Zone Type of study: Clinical_trials / Systematic_reviews Limits: Child / Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: